Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

365

HTML

2553

Tables (1-3)

234

Sum=3152

Feb 14, 2010 (publication date) through Jan 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2010; 16(6): 740-744
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.740

Table 3 Outcomes of the patients

Patient No.	Additional therapy (systemic)	Survival (d)	Cause of death
1	5-Fu + CDDP	126	Lung and pleural metastases
2	5-Fu + CDDP	268	Pleural metastases
3	5-Fu + CDDP	137	Lung and bone metastases
4	-	68	Lung and pleural metastases
5	-	61	Lung and bone metastases
6	-	104	Lung and pleural metastases
7	-	77	Pleural metastases

5-Fu: 5-fluorouracil.

Citation: Oida T, Mimatsu K, Kano H, Kawasaki A, Kuboi Y, Fukino N, Amano S. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol 2010; 16(6): 740-744
URL: https://www.wjgnet.com/1007-9327/full/v16/i6/740.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i6.740